Cargando…

Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment

INTRODUCTION: Rheumatoid arthritis (RA) is frequently complicated with infections. The aim of our study was to evaluate vaccination response in patients with RA after B-cell depletion by using rituximab. METHODS: Influenza (Afluria) and pneumococcal polysaccharides (Pneumo23) vaccines were given 6 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rehnberg, Maria, Brisslert, Mikael, Amu, Sylvie, Zendjanchi, Kiandoht, Håwi, Gunilla, Bokarewa, Maria I
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911904/ https://www.ncbi.nlm.nih.gov/pubmed/20529331 http://dx.doi.org/10.1186/ar3047

Ejemplares similares

Epstein–Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment
por: Magnusson, Mattias, et al.
Publicado: (2010)

Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
por: Rehnberg, Maria, et al.
Publicado: (2009)

Suppressed diversity of survivin splicing in active rheumatoid arthritis
por: Turkkila, Minna, et al.
Publicado: (2015)

Phenotype and Function of CD25-Expressing B Lymphocytes Isolated from Human Umbilical Cord Blood
por: Amu, Sylvie, et al.
Publicado: (2011)

The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis
por: Ekwall, Anna-Karin H, et al.
Publicado: (2011)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Mice Chronically Fed High-Fat Diet Have Increased Mortality and Disturbed Immune Response in Sepsis
por: Strandberg, Louise, et al.
Publicado: (2009)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Rituximab for the treatment of rheumatoid arthritis: an update
por: Mok, Chi Chiu
Publicado: (2013)

Rituximab treatment in rheumatoid arthritis: how does it work?
por: Boumans, Maria JH, et al.
Publicado: (2009)

Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study
por: Bokarewa, Maria, et al.
Publicado: (2014)

Rituximab and its potential for the treatment of rheumatoid arthritis
por: Bryant, Adam, et al.
Publicado: (2006)

Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Tsiakalos, Aristotelis P, et al.
Publicado: (2008)

Update on the use of rituximab for intractable rheumatoid arthritis
por: Looney, R John
Publicado: (2009)

Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis
por: Bokarewa, Maria, et al.
Publicado: (2005)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Long-term persistence with rituximab in patients with rheumatoid arthritis
por: Oldroyd, Alexander G S, et al.
Publicado: (2018)

Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
por: Kilic, Levent, et al.
Publicado: (2018)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy, Hasan, et al.
Publicado: (2020)

Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis
por: Osborn, Teresia M, et al.
Publicado: (2008)

Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis
por: Cohen, Stanley B., et al.
Publicado: (2018)

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
por: Crnkic Kapetanovic, Meliha, et al.
Publicado: (2013)

Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab
por: Conigliaro, Paola, et al.
Publicado: (2016)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Tuscano, Joseph M, et al.
Publicado: (2009)

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2011)

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis
por: Lehane, P B, et al.
Publicado: (2014)

Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis
por: Sweeney, Shannon R, et al.
Publicado: (2016)

(Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges
por: den Broeder, Alfons A, et al.
Publicado: (2021)

Enteroviral Meningoencephalitis as a Complication of Rituximab Therapy for Rheumatoid Arthritis
por: Cook, Samuel G, et al.
Publicado: (2021)

Clinical Significance of Diabetes-Mellitus-Associated Antibodies in Rheumatoid Arthritis
por: Erlandsson, Malin C., et al.
Publicado: (2022)

Fms-Like Tyrosine Kinase 3 Ligand Controls Formation of Regulatory T Cells in Autoimmune Arthritis
por: Svensson, Mattias N. D., et al.
Publicado: (2013)

Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab
por: Benucci, Maurizio, et al.
Publicado: (2021)

Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
por: Vallerskog, Therese, et al.
Publicado: (2006)

Humoral response to coronavirus disease-19 vaccines is dependent on dosage and timing of rituximab in patients with rheumatoid arthritis
por: van der Togt, Céleste J T, et al.
Publicado: (2022)

Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
por: Pullerits, Rille, et al.
Publicado: (2005)

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Reddy, Venkat, et al.
Publicado: (2015)

Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis
por: Díaz-Torné, Cèsar, et al.
Publicado: (2019)

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
por: Hainsworth, John D
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_3l9nkplj35ih4fk0j2i5ued0j0